Business Wire

COMPUTEX 2019 Ended Successfully

Del

COMPUTEX 2019 closed today (June 1) with a huge success. In the last five days, 42,495 international buyers from 171 countries flooded into the show, a 0.5% growth from the previous year. The top 10 buyer countries are, namely, China, the US, Japan, South Korea, Hong Kong, Thailand, Singapore, Germany, Malaysia, and India. Once again, COMPUTEX established the role of a leading ICT tradeshow that connects businesses along industry supply chains and opens up infinite possibilities in the tech ecosystem. In addition, InnoVEX 2019 attracted 18,251 visitors in 3 days, a 3% from the previous year, showing significant startup dynamics. During the show, 76 heavyweight buyers from around the world participated in 470 sessions of one-on-one procurement meetings. Furthermore, InnoVEX invited 45 international venture capital firms, including Samsung NEXT, LINE, Delta, China Trust, and Israel's largest fundraising platform, OurCrowd, to match with 69 startups.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190601005035/en/

(Photo: Business Wire)

(Photo: Business Wire)

Myriads of Gaming Devices Launched; New-Generation High-Performance Products Glowed

With the advancements and introduction of new AAA games based on generous production budgets and marketing cost, PC manufacturers are taking up challenges to break technological boundaries. The development of high-performance multitasking processors, graphics cards, memory, and high-end peripherals is indicating that these brands are catering to professional eSports players and enthusiastic gamers, meeting their demands and expectations for immersive gaming experiences.

MSI’s flagship GT76 Titan gaming laptop showcased at COMPUTEX was armed with an Intel® Core™ i9 processor that can be overclocked to 5.0GHz across all 8 cores, while its extreme cooling capability handles the most extreme heat, granting the new GT Titan its overclocked desktop performance. ADATA showcased its XPG ORB that presents all XPG products and offers immersive experiences. ASRock introduced its Phantom Gaming motherboards while its premium Z390 Phantom Gaming X received the most attention at COMPUTEX for being the first motherboard in the world to support Wi-Fi 6 (802.11ax), providing improved thermal result and superior performance.

Inspiring eSports Games Held for Charity on the International Stage

As the first charity eSports event held at COMPUTEX, ZOTAC CUP Fight for Charity LOL Tournament ended today. A total Grand Finals prize pool of US$100,000 will go towards charities including Esports Foundation in the US, Gaming Aid in Germany and Make-A-Wish Foundation. ZOTAC successfully made positive impacts and give back for a good cause.

G.Skill OC World Record Stage 2019 and OC World Cup 2019—organized by G.Skill and sponsored by Samsung and Intel—ended with championship taken by Alex@ro from Romania. The 8th G.Skill OC World Record Overclocking Competition invited 15 overclockers to represent the major e-sports vendors to demonstrate the powerful hardware performance on the spot. And in addition to the overclocking contest, G.Skill Extreme Mod Stage 2019, on the other hand, invited 10 teams of talented system mod builders to bring their creativity into full play at COMPUTEX and presented 11 of the world’s most creative and special system mods.

Promising Startups From Around the World Gathered at InnoVEX, Pitch Competition Awards Delivered

As a global indicator, InnoVEX is a platform that encourages startups to show their unlimited creativity and offers publicity opportunities. Every year at InnoVEX, a pitch competition is held. This year, the total award reached US$420,000. The grand prize worthy of US$30,000 was taken by MedFluid. Omni Eyes, Mind & Idea Fly, Onesoftdigm, MedFluid, and PurCity left with Startup Terrace Awards and US$ 60,000. MTAMTech was awarded US$10,000 by Taiwania Capital and Ganzin technology received US$10,000 award by Qualcomm.

For the first time, a CEO Keynote was held with COMPUTEX pre-show International Press Conference with AMD President & CEO Dr. Lisa Su as the keynote speaker. Dr. Lisa Su addressed how the next-generation of computing will drive innovation. She also invited Microsoft, ASUS, Acer and close to 20 industry partners to present the computing industry ecosystem. Leonor Lin, TAITRA Executive Vice President said, “This year, we have seen various innovative applications driven by the advancements of AI, IoT, and 5G. The technologies to process a massive amount of data and high-performance computing will be one of the most important driving forces to sustain the growth of the tech industry in the future. COMPUTEX 2019 has fulfilled its promise to build global tech ecosystems. As the scope of exhibitions and the number of participants set new records, we expect COMPUTEX to keep leading technology businesses forward to build global technology ecosystems that bring prosperity to all.”

For more updated show info:

COMPUTEX Website:http://www.computextaipei.com.tw/zh_TW/
COMPUTEX Facebook:https://www.facebook.com/COMPUTEX.TAITRA/

About COMPUTEX TAIPEI (also called COMPUTEX):

Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.

About TAITRA:

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,200 trained specialists stationed throughout its Taipei headquarters, five local branch offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

In addition to organizing trade delegations & providing customized procurement services, TAITRA also hosts more than 35 international trade shows annually in Taipei and Kaohsiung.

Contact information

Press Contact:
Belinda Chen (TAITRA)
cpx-press1@taitra.org.tw

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors17.6.2019 16:00:00 CESTPressemelding

Boehringer Ingelheim and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class monoclonal antibody antagonist of SIRPα, being studied in patients with advanced solid tumors. The Phase 1 study is a dose finding study of BI 765063, a myeloid checkpoint inhibitor, administered as a single agent and in combination with Boehringer Ingelheim’s monoclonal antibody PD-1 antagonist BI 754091, a T-lymphocyte checkpoint inhibitor. “We are very pleased with the progress achieved on BI 765063’s program and having the first patient dosed marks a significant milestone in the product’s development. The advancement of a myeloid cell checkpoint blocking monoclonal antibody into the clinic exemplifies Boehringer Ingelheim’s commitment to the next wave of innovation in cancer immunology therapies, with the goal of meaningfully improving outcomes fo

MagicStay Raises €3 Million to Accelerate Its International Development17.6.2019 15:58:00 CESTPressemelding

The apartment rental platform dedicated to business travelers, MagicStay.com , announces its full integration into the main business travel booking tools and a €3 million A-series to pursue its development, bringing the amounts raised to more than €8 million since its launch in 2013. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005644/en/ William Lecerf and Valéry Linyer, co-founders of MagicStay (Photo: MagicStay) "This fundraising will allow us to recruit talent to accelerate our growth. We want to sign a quarter of the major French companies and approach one million homes before the end of the year, thanks to the exclusive technologies we now have at our disposal", says Valéry Linÿer, CEO and co-founder, who adds: "We have four main advantages over our competitors: we meet the challenges of duty of care, we are able to customize our tool to meet the constraints of each large company for short and long stays, we ha

EURid Shows a 94% Reduction of Its Footprint since 201217.6.2019 15:32:00 CESTPressemelding

EURid, the not-for-profit organisation that operates the .eu and .ею top-level domains, is the first European TLD registry that registered for the EU Eco-Management and Audit Scheme (EMAS) from 2011. Since then, EURid has regularly assessed the environmental impact of its activities and monitored the compliance of its policies and procedures. As over the past four years, in Q2 2019 EURid was audited for the CO2 emissions of the previous year, resulting in an overall footprint of 135 tons CO2eq, which shows a 94% reduction since 2012. “We have achieved carbon neutrality via several actions and the compensation of the audited emissions. We were and are still among the first in our sector to report on our commitment to protect the environment”, commented CEO Marc Van Wesemael. Through EMAS, EURid has had the opportunity to support a multitude of global sustainability initiatives, like the Ugandan Borehole Project, Ecomapuà Project in the Amazon, the Dak Rung Hydropower Project in Vietnam,

Animation, Sound & Vibration – How Visa is Reinforcing Consumer Trust in a Changing Payments World17.6.2019 15:00:00 CESTPressemelding

Visa (NYSE: V) today announced global adoption of its sensory branding suite in 25 countries via more than a dozen new partnerships. The suite is comprised of sound, animation and haptic brand cues that occur with a Visa payment transaction. In a digital world increasingly filled with voice-commands, networked appliances and unattended retail environments, Visa’s sensory branding cues offer new ways to enhance the customer experience and convey the trust and security that the Visa brand represents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005240/en/ Visa was the first major payment brand to introduce multi-sensory branding, which included animation, sound and haptic vibration expressions of its brand. After an extensive creation and selection process that involved focus groups and elimination rounds, Visa landed on a single ‘energetic’ and ‘optimistic’ sound, and complementary animation and haptic vibration. Sinc

Study from Project Management Institute Identifies Six AI Technologies Impacting Project Professionals17.6.2019 14:40:00 CESTPressemelding

Project Management Institute (PMI) today released its 2019 Pulse of the Profession® In-Depth Report: AI Innovators: Cracking the Code on Project Performance. The report provides an in-depth look at how artificial intelligence (AI) is impacting organizations and the project management profession. Findings reveal that AI disruption is happening and at a large scale: 81 percent of respondents report their organization is being impacted by AI technologies; 37 percent say adopting AI technologies is a high priority for their organization; and project professionals say they expect the proportion of the projects they manage using AI will jump from 23 to 37 percent over the next three years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005558/en/ These insights from a survey of 551 project management practitioners globally show that the presence of AI technologies will continue to grow, requiring shifts in how projects are m

RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration17.6.2019 13:15:00 CESTPressemelding

RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced positive top-line results from its SUSHI study, Phase 1/2a single ascending dose clinical study of RBM-007, anti-FGF2 aptamer, in nine subjects with wet Age-Related Macular Degeneration (wet AMD). SUSHI study achieved the primary endpoint of safety and tolerability, and also demonstrated efficacy trends in favor of RBM-007. Subjects recruited for the SUSHI Study had wet AMD that was poorly responsive to previous intravitreal anti-VEGF therapy. Through the 56-Day exit visit, excluding one uncompleted case in the last cohort, single dose of RBM-007 demonstrated no dose-limiting toxicities, no systemic or ocular serious adverse events. One subject in Cohort 3 showed anterior inflammation, which was resolved after one day of topical prednisolone treatment. Rescue treatment with anti-VEGF therapy was ava